Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2003 March;47(1) > The Quarterly Journal of Nuclear Medicine 2003 March;47(1):63-74

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E.
 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):63-74

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments

Berk F., Demir H., Aktolun C

Department of Nuclear Medicine, Kocaeli University, School of Medicine, Kocaeli, Turkey


PDF


The advan­tag­es and lim­i­ta­tions of 201Tl imag­ing in assess­ing the ­tumor ­response to ­anti-can­cer ther­a­py are dis­cussed in ­this ­review. 201Tl has dis­tinc­tive advan­tag­es but ­more ­recent ­agents ­such as 99mTc ­MIBI and posi­tron emit­ters ­have ­some clin­i­cal super­ior­ities ­over 201Tl in ­this ­usage.

top of page